CHRIS DOERR: Open Payments
NPI 1003990771 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$105 in 5 payments from 5 companies in 2025. Trend: 2023 $78 · 2024 $155 · 2025 $105
Food & beverage: $105
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: CAPLYTA, ARISTADA, INGREZZA, REXULTI, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
